Kava remains a controlled substance in Thailand. As of 2024, the Plant Quarantine Act and the Narcotics Act prohibit the sale, import‑for‑consumption and public use of kava (Piper methysticum). Only limited research‑related importation under a permit is permitted. The government has announced a review of traditional herbal relaxants, and a draft amendment slated for parliamentary debate in early 2025 could relax restrictions, but no definitive change is scheduled for 2026. In short, today kava is illegal for recreational or commercial use, and any legal shift by 2026 remains uncertain.
Current Legal Status
Thailand’s narcotics legislation classifies kava as a “psychotropic plant” without an exemption for traditional or culinary use. Enforcement agencies confiscate kava shipments and prosecute vendors under the Narcotics Act. Academic institutions may apply for a research permit from the Food and Drug Administration (FDA) and the Ministry of Agriculture, which allows limited import of dried roots or extracts for laboratory analysis. Possession for personal use can lead to fines up to 200,000 baht and imprisonment of up to two years.
Prospects for Change in 2026
A bipartisan committee on traditional medicine began drafting a “Herbal Relaxant Regulation” in late 2023. The proposal would create a separate schedule for botanicals like kava, permitting regulated sale in licensed tea houses and herbal shops, provided the product contains no more than 25 mg of kavalactones per serving. The draft was submitted to the House of Representatives in March 2025, with a scheduled vote in the 2025‑2026 legislative session. Critics argue that insufficient toxicology data could delay approval, while supporters point to growing tourism interest in natural anxiolytics. Until the bill passes and the accompanying FDA guidelines are issued, the existing prohibition remains in force.
Key Takeaways
- Presently illegal for personal consumption or commercial sale.
- Research‑only permits are available through the FDA and Ministry of Agriculture.
- Legislative review is underway; a 2025‑2026 vote could create a regulated market.
- No guarantee that the rules will be altered by the start of 2026.
- Travelers should avoid bringing kava into Thailand to prevent customs seizures.
Is it possible to bring kava into Thailand for personal use?
No. Customs officials treat kava as a prohibited plant. Even small amounts for personal consumption can be seized and result in fines or criminal charges. The only lawful import is under a research permit issued to a qualified institution.
Can Thai citizens grow kava at home?
Cultivation of kava without a license is prohibited. The Plant Quarantine Act requires a permit for importing planting material, and the Narcotics Act bans the cultivation of psychoactive plants outside authorized research farms. Violations can lead to seizure of the plants and penalties similar to possession offenses.
Are there any medical exceptions for kava in Thailand?
Yes, but only in a highly regulated context. Hospitals and research centers may request a special exemption from the FDA to use kava extracts in clinical trials or as part of an investigational new drug (IND) application. Such use is strictly monitored, and the product must meet Thai Good Manufacturing Practice (GMP) standards.
How does Thailand’s stance compare with neighboring countries?
Malaysia and Singapore classify kava as a controlled substance, whereas Vietnam and Indonesia allow limited commercial sale of kava beverages under food‑safety regulations. Thailand’s stricter approach reflects concerns about kava‑related liver toxicity and the lack of a long‑standing cultural tradition of consumption.
What should tourists do if they are offered kava in Thailand?
Politely decline and explain that kava is illegal for consumption. Accepting or purchasing it could expose the individual to legal risk, including detention and fines. Opt for legally available Thai herbal drinks such as lemongrass tea or ginger infusion, which are widely served in cafés and pose no regulatory issues.
